Why the study?
Increasing evidence shows lncRNAs play pivotal roles in adipose tissue development and the progression of diseases induced by adipose dysfunction, highlighting a need to summarize their roles to identify novel drug targets.
Key points are not available for this paper at this time.
Design
Review
This review highlights the emerging role of long noncoding RNAs in adipogenesis and adipose tissue function, suggesting their potential as novel drug targets for obesity and metabolic diseases.
Obesity, a global public health issue, is characterized by excessive adiposity and is strongly related to some chronic diseases including cardiovascular diseases and diabetes. Extra energy intake-induced adipogenesis involves various transcription factors and long noncoding RNAs (lncRNAs) that control lipogenic mRNA expression. Currently, lncRNAs draw much attention for their contribution to adipogenesis and adipose tissue function. Increasing evidence also manifests the pivotal role of lncRNAs in modulating white, brown, and beige adipose tissue development and affecting the progression of the diseases induced by adipose dysfunction. The aim of this review is to summarize the roles of lncRNAs in adipose tissue development and obesity-caused diseases to provide novel drug targets for the treatment of obesity and metabolic diseases.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: